Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Parkinson Disease × Iodine-123 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 2 Thyroid Neoplasms 1 Primary Breast Cancer 1 Parkinson Disease 1 Malignancy of Thyroid Nodules 1

Interventions

fluorodopa F 18 2 Tomography, Emission-Computed, Single-Photon 1 Positron Emission Tomography Computed Tomography 1 Medical Marijuana 1 Iodine-124 1 Iodine-123 1 Furosemide 1 Exergaming 1 4-chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01931488 2013-08-29

124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.

Tel-Aviv Sourasky Medical Center

Phase 2 Unknown

Parkinson Disease, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡